数位疫苗市场规模、份额和成长分析（按类型、部署模式、最终用户和地区）- 2025-2032 年产业预测

2023 年全球数位疫苗市场规模价值 20 亿美元，预计将从 2024 年的 22.2 亿美元成长到 2032 年的 50.3 亿美元，预测期间（2025-2032 年）的复合年增长率为 10.8%。

数位疫苗是一种变革性的方法，透过神经认知训练和推动技术改变行为模式，从而促进身心健康。这些工具采用虚拟实境、智慧型手机应用程式和人工智慧等先进的数位技术，旨在以经济有效的方式培养积极的习惯并改善心理健康。医疗 IT 市场的快速扩张，以及物联网、穿戴式科技、AR/VR 等技术创新，正在增强针对各种健康挑战的频繁行为介入的实施。美国国防部的虚拟 PTSD 体验等措施展示了虚拟实境在心理健康护理领域的潜力。随着人工智慧和机器学习推动引人注目的应用程式的发展，数位疫苗在促进更健康的生活方式方面显示出希望，尤其是在年轻人中。此类创新对未来的影响是巨大且前景光明的。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

数位疫苗市场规模（按类型和复合年增长率） (2025-2032)

• 市场概况
• 疫苗管理软体
• 疫苗接种追踪应用程式
• 数位平台

数位疫苗市场规模（按部署模式和复合年增长率） (2025-2032)

• 市场概况
• 云端基础
• 本地

数位疫苗市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医疗保健提供者
• 製药和生物技术公司
• 政府和公共卫生机构
• 研究机构和学术中心
• 患者和看护者

数位疫苗市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Pfizer（US）
• Moderna（US）
• Johnson & Johnson（US）
• AstraZeneca（UK）
• Merck（US）
• Sanofi（France）
• GSK（UK）
• Novavax（US）
• BioNTech（Germany）
• Bharat Biotech（India）
• Microsoft（US）
• IBM（US）
• Oracle（US）
• Salesforce（US）
• Amazon（US）
• Google（US）
• McKesson（US）
• AmerisourceBergen（US）
• CVS Health（US）
• Walgreens Boots Alliance（US）

结论和建议

Global Digital Vaccine Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.22 billion in 2024 to USD 5.03 billion by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

Digital vaccines represent a transformative approach to promoting mental and physical well-being by modifying behavioral patterns through neurocognitive training and nudging techniques. Utilizing advanced digital technologies such as virtual reality, smartphone apps, and artificial intelligence, these tools aim to foster positive habits and improve mental health affordably and effectively. The rapid expansion of the healthcare IT market, alongside innovations like the Internet of Things, wearable tech, and AR/VR, enhances the delivery of frequent behavioral interventions across various health challenges. Initiatives like the US Department of Defense's Virtual PTSD Experience exemplify the potential of virtual reality in mental health care. With AI and machine learning driving the development of engaging applications, digital vaccines hold promise in cultivating healthier lifestyles, particularly among youth. The future impact of these innovations is both vast and promising.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Vaccine Market Segments Analysis

Global Digital Vaccine Market is segmented by Type, Deployment mode, End user and region. Based on Type, the market is segmented into Vaccine management software, vaccination tracking applications and digital platforms. Based on Deployment mode, the market is segmented into Cloud-based and on-premise. Based on End user, the market is segmented into Healthcare providers, pharmaceutical & biotechnology companies, government & public health agencies, research institutes & academic centers and patients & caregivers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Vaccine Market

The Global Digital Vaccine market is being significantly driven by a growing emphasis on immunization programs from governments and healthcare organizations across the globe, aimed at curtailing the spread of infectious diseases. This increased focus has spurred a demand for digital vaccine solutions to boost the efficiency and effectiveness of vaccination initiatives. For instance, the World Health Organization's Global Vaccine Action Plan strives to enhance vaccination coverage while ensuring equitable access to vaccines. Digital tools, such as mobile applications for scheduling appointments and sending reminders, empower healthcare providers to better connect with target populations, ultimately leading to improved vaccination rates and health outcomes.

Restraints in the Global Digital Vaccine Market

The Global Digital Vaccine market faces significant constraints related to the collection, storage, and sharing of sensitive health data within digital vaccination systems, which raises important issues surrounding data privacy and security. Ensuring the protection of personal health information and confidentiality of vaccination records is vital. The absence of effective security measures could lead to data breaches and unauthorized access, which can undermine public trust. Therefore, it is imperative to address these privacy concerns and adopt stringent data protection protocols to foster confidence and promote the widespread acceptance and use of digital vaccine solutions in the market.

Market Trends of the Global Digital Vaccine Market

The Global Digital Vaccine market is experiencing a notable trend towards integrating blockchain technology to enhance the security and transparency of vaccine supply chains. As stakeholders increasingly seek to combat counterfeit products and ensure the integrity and proper handling of vaccines, blockchain's decentralized and tamper-resistant ledger system emerges as a robust solution. Initiatives such as IBM's "Blockchain for Vaccines" showcase the potential of this technology to track vaccines from manufacturer to patient, providing clear traceability and auditability. This shift not only addresses the pressing concerns of vaccine integrity but also bolsters consumer confidence and supports streamlined operations within the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Digital Vaccine Market Size by Type & CAGR (2025-2032)

• Market Overview
• Vaccine management software
• vaccination tracking applications
• digital platforms

Global Digital Vaccine Market Size by Deployment mode & CAGR (2025-2032)

• Market Overview
• Cloud-based
• on-premise

Global Digital Vaccine Market Size by End user & CAGR (2025-2032)

• Market Overview
• Healthcare providers
• pharmaceutical & biotechnology companies
• government & public health agencies
• research institutes & academic centers
• patients & caregivers

Global Digital Vaccine Market Size & CAGR (2025-2032)

• North America (Type, Deployment mode, End user)
  • US
  • Canada
• Europe (Type, Deployment mode, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Deployment mode, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Deployment mode, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Deployment mode, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Salesforce (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amazon (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Google (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CVS Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walgreens Boots Alliance (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations